These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 12738737

  • 1. Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells.
    de la Taille A, Rubin MA, Chen MW, Vacherot F, de Medina SG, Burchardt M, Buttyan R, Chopin D.
    Clin Cancer Res; 2003 May; 9(5):1801-7. PubMed ID: 12738737
    [Abstract] [Full Text] [Related]

  • 2. Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis.
    Mulholland DJ, Read JT, Rennie PS, Cox ME, Nelson CC.
    Oncogene; 2003 Aug 28; 22(36):5602-13. PubMed ID: 12944908
    [Abstract] [Full Text] [Related]

  • 3. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential.
    Murakami T, Toda S, Fujimoto M, Ohtsuki M, Byers HR, Etoh T, Nakagawa H.
    Biochem Biophys Res Commun; 2001 Oct 19; 288(1):8-15. PubMed ID: 11594745
    [Abstract] [Full Text] [Related]

  • 4. Transactivation of vimentin by beta-catenin in human breast cancer cells.
    Gilles C, Polette M, Mestdagt M, Nawrocki-Raby B, Ruggeri P, Birembaut P, Foidart JM.
    Cancer Res; 2003 May 15; 63(10):2658-64. PubMed ID: 12750294
    [Abstract] [Full Text] [Related]

  • 5. Cleavage of beta-catenin by calpain in prostate and mammary tumor cells.
    Rios-Doria J, Kuefer R, Ethier SP, Day ML.
    Cancer Res; 2004 Oct 15; 64(20):7237-40. PubMed ID: 15492240
    [Abstract] [Full Text] [Related]

  • 6. A human- and male-specific protocadherin that acts through the wnt signaling pathway to induce neuroendocrine transdifferentiation of prostate cancer cells.
    Yang X, Chen MW, Terry S, Vacherot F, Chopin DK, Bemis DL, Kitajewski J, Benson MC, Guo Y, Buttyan R.
    Cancer Res; 2005 Jun 15; 65(12):5263-71. PubMed ID: 15958572
    [Abstract] [Full Text] [Related]

  • 7. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc.
    Sasaki T, Suzuki H, Yagi K, Furuhashi M, Yao R, Susa S, Noda T, Arai Y, Miyazono K, Kato M.
    Cancer Res; 2003 Feb 15; 63(4):801-6. PubMed ID: 12591729
    [Abstract] [Full Text] [Related]

  • 8. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
    Esufali S, Bapat B.
    Oncogene; 2004 Oct 28; 23(50):8260-71. PubMed ID: 15377999
    [Abstract] [Full Text] [Related]

  • 9. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
    Shiina H, Igawa M, Breault J, Ribeiro-Filho L, Pookot D, Urakami S, Terashima M, Deguchi M, Yamanaka M, Shirai M, Kaneuchi M, Kane CJ, Dahiya R.
    Clin Cancer Res; 2003 Jun 28; 9(6):2121-32. PubMed ID: 12796377
    [Abstract] [Full Text] [Related]

  • 10. Loss of beta-catenin expression in metastatic gastric cancer.
    Ebert MP, Yu J, Hoffmann J, Rocco A, Röcken C, Kahmann S, Müller O, Korc M, Sung JJ, Malfertheiner P.
    J Clin Oncol; 2003 May 01; 21(9):1708-14. PubMed ID: 12721245
    [Abstract] [Full Text] [Related]

  • 11. Beta-catenin can act as a nuclear import receptor for its partner transcription factor, lymphocyte enhancer factor-1 (lef-1).
    Asally M, Yoneda Y.
    Exp Cell Res; 2005 Aug 15; 308(2):357-63. PubMed ID: 15936755
    [Abstract] [Full Text] [Related]

  • 12. Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis.
    Jung HC, Kim K.
    Life Sci; 2005 Jul 29; 77(11):1249-62. PubMed ID: 15979100
    [Abstract] [Full Text] [Related]

  • 13. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
    Wu R, Zhai Y, Fearon ER, Cho KR.
    Cancer Res; 2001 Nov 15; 61(22):8247-55. PubMed ID: 11719457
    [Abstract] [Full Text] [Related]

  • 14. The emergence of protocadherin-PC expression during the acquisition of apoptosis-resistance by prostate cancer cells.
    Chen MW, Vacherot F, De La Taille A, Gil-Diez-De-Medina S, Shen R, Friedman RA, Burchardt M, Chopin DK, Buttyan R.
    Oncogene; 2002 Nov 07; 21(51):7861-71. PubMed ID: 12420223
    [Abstract] [Full Text] [Related]

  • 15. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters.
    Gustavson MD, Crawford HC, Fingleton B, Matrisian LM.
    Mol Carcinog; 2004 Nov 07; 41(3):125-39. PubMed ID: 15457508
    [Abstract] [Full Text] [Related]

  • 16. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE, Wang MX, Li RQ.
    Cancer Invest; 2009 Jul 07; 27(6):604-12. PubMed ID: 19440933
    [Abstract] [Full Text] [Related]

  • 17. Rare activation of the TCF/beta-catenin pathway in ovarian cancer.
    Furlong MT, Morin PJ.
    Gynecol Oncol; 2000 Apr 07; 77(1):97-104. PubMed ID: 10739697
    [Abstract] [Full Text] [Related]

  • 18. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
    Torres VA, Tapia JC, Rodriguez DA, Lladser A, Arredondo C, Leyton L, Quest AF.
    Mol Cell Biol; 2007 Nov 07; 27(21):7703-17. PubMed ID: 17785436
    [Abstract] [Full Text] [Related]

  • 19. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.
    Cancer Res; 2004 Oct 01; 64(19):7156-68. PubMed ID: 15466214
    [Abstract] [Full Text] [Related]

  • 20. Beta-catenin inhibits cell growth of a malignant mesothelioma cell line, NCI-H28, with a 3p21.3 homozygous deletion.
    Usami N, Sekido Y, Maeda O, Yamamoto K, Minna JD, Hasegawa Y, Yoshioka H, Imaizumi M, Ueda Y, Takahashi M, Shimokata K.
    Oncogene; 2003 Sep 11; 22(39):7923-30. PubMed ID: 12970740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.